In the rapidly evolving field of cancer therapeutics, understanding the intricate mechanisms of Antibody-Drug Conjugates (ADCs) is crucial for developing effective treatments. One of the most promising approaches is the use of in vitro bystander effect assays, which play a pivotal role in enhancing therapeutic efficacy. These assays, provided by companies like ICE Bioscience, evaluate how cytotoxic payloads from ADCs affect both target antigen-positive and neighboring antigen-negative cancer cells. By incorporating advanced techniques such as real-time imaging and flow cytometry, these assays provide comprehensive insights into ADC interactions. For those engaged in adc discovery services , employing these assays can significantly optimize the design and functionality of ADCs, ultimately improving patient outcomes.   Table of contents: The Science Behind ADC Bystander Effect Assays and Their Benefits Leveraging In Vitro Bystander Effect Assays for Improved ADC Design How Bysta...